Company Email Format Management

Chimeron Bio

Biotechnology Research 601 Walnut Street 11 employees

Employees: 11
Contacts: 3
Emails: 3
Phones: 1

chimeronbio.com LinkedIn Crunchbase

Chimeron Bio Overview

Headquarters: 601 Walnut Street
Website: chimeronbio.com
Industry: Biotechnology Research
Employees: 11
Funding: 12.8M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

in 𝗖𝗔𝗥-𝗧 𝗮𝗻𝗱 𝗖𝗔𝗥-𝗡𝗞 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺𝘀

About Chimeron Bio

Chimeron Bio is an early-stage biotechnology company developing innovative, off-the-shelf therapies to transform cancer treatment. Our mission is to unlock the full potential of in vivo CAR-T by delivering multi-gene, multi-mechanism constructs directly inside the body. We aim to create potent, durable, and precise cell therapies that are both scalable and accessible. Our non-viral approach enables a new class of multiplex in vivo CAR-T treatments designed to tackle the complexity of solid tumors. In parallel, we are advancing complementary immuno-oncology programs to further our therapeutic impact. This disruptive approach has the potential to redefine the standard for cell and gene therapies in oncology.

Chimeron Bio Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 1; 25.0% coverage

Chimeron Bio Org Chart

Sample employees and titles

Name	Title	Location	Contact
Afshin Safavi	Biotech Entrepreneur - Founder	Denver Metropolitan Area, United States	Email Phone
Satish Adhikari, Phd	Manager - Platform Development	Philadelphia, Pennsylvania, United States	Email
Robert Willette	Interim Chief Scientific Officer	Pottstown, Pennsylvania, United States	Email
Monica Coleman		Apex, North Carolina, United States	View